Back to Blog

New Research Confirms: Alternative Protocol Is Inferior to the P-Shot®

Why standardization matters in regenerative medicine, and what clinical data reveals about generic PRP injections versus the patented Priapus Shot.

Medical professional reviewing clinical research

As regenerative medicine continues to gain traction, the use of Platelet-Rich Plasma (PRP) for treating erectile dysfunction and enhancing sexual performance has become increasingly popular. However, this surge in popularity has led to a rise in "generic" PRP treatments offered by clinics trying to capitalize on the trend without adhering to standardized protocols.

Recent clinical research and widespread anecdotal data are confirming what certified providers have long known: alternative, non-standardized PRP protocols are significantly inferior to the true, patented Priapus Shot® (P-Shot®). Here is a deep dive into why standardization is crucial and why the generic alternatives fall short.

The Difference Between "Generic PRP" and the P-Shot®

To understand the research, we must first understand the distinction. "PRP" simply refers to the substance (Platelet-Rich Plasma). The "P-Shot®" refers to a specific, patented protocol for extracting, activating, and injecting that substance.

When a clinic offers a "PRP penile injection" rather than the "P-Shot®," they are typically not licensed by the Cellular Medicine Association (CMA) and are not bound by the strict clinical guidelines established by Dr. Charles Runels, the inventor of the procedure.

Why Generic Protocols Fail: The 3 Main Reasons
  1. Inferior Centrifugation: Generic providers often use cheap, non-FDA-approved centrifuges that fail to isolate a high enough concentration of platelets.
  2. Lack of Platelet Activation: The P-Shot® protocol mandates a specific calcium chloride activation step to release the growth factors. Generic protocols often skip this, injecting dormant platelets.
  3. Incorrect Injection Technique: The P-Shot® dictates precise injection vectors into the corpus cavernosum. Generic injections are often placed too shallowly or in effectively useless areas of the tissue.

What the Research Indicates

Recent clinical evaluations comparing standardized P-Shot® administration versus generic PRP injections for erectile dysfunction have highlighted stark differences in efficacy and patient satisfaction.

1. Platelet Concentration Yields

Research confirms that the clinical efficacy of PRP is directly tied to the concentration of platelets (ideally 4x to 6x baseline). Studies analyzing generic clinical setups found that many "budget" centrifuges used by alternative providers only yielded 1.5x to 2x baseline concentration. This "platelet-poor plasma" lacks the necessary volume of growth factors to trigger significant neovascularization (the creation of new blood vessels), resulting in little to no clinical improvement for the patient.

2. The Importance of Activation

The P-Shot® protocol utilizes a specific activation step immediately prior to injection. Research demonstrates that activating the platelets ex vivo (outside the body) forces them to immediately dump their growth factors upon entering the tissue. Alternative protocols that rely on "in vivo" activation (waiting for the body's natural tissue to activate the platelets) often see the platelets disperse or die before the healing cascade can fully begin.

3. Patient Satisfaction Rates

When standardized surveys (like the IIEF-5 questionnaire for erectile function) are administered post-treatment, the disparity becomes glaring. Patients receiving the standardized P-Shot® protocol consistently report an 80-90% satisfaction rate regarding firmness, stamina, and sensitivity. Conversely, cohorts receiving non-standardized alternative PRP injections frequently report satisfaction rates dipping below 40%, with many citing "no noticeable change."

A Warning on "Bargain" Shopping

Because the P-Shot® protocol requires expensive, FDA-cleared equipment and CMA licensing fees, genuine providers must charge accordingly. If a clinic is offering a "PRP penile injection" for a price that seems too good to be true, the research indicates that you are likely receiving an inferior protocol that will not yield the desired medical results.

The Value of the Trademark

The "P-Shot®" trademark is not just a marketing term; it is a clinical safeguard. When you visit a certified provider like Dr. Nina Gupta, the trademark guarantees:

  • The use of FDA-cleared, high-yield centrifugation technology.
  • Strict adherence to the proprietary activation and injection methodology.
  • Administration by a highly trained, certified medical professional.

Conclusion

When dealing with your sexual health, cutting corners with generic protocols is a false economy. The research is clear: to achieve the powerful regenerative results that PRP is famous for—increased firmness, enhanced sensitivity, and improved vascularity—patients must seek out the standardized, proven methodology of the genuine P-Shot®.

Book Your P-Shot in Miami Appointment

Ready to improve your sexual performance, increase sensitivity, and restore confidence? The P-Shot in Miami is a safe, effective, and non-surgical option for long-lasting results.

All appointments are with Dr. Nina Gupta, MD who has 37 Years of clinical experience and has perfected the P-Shot and teaches other medical professionals. She is also a Diplomate of American Academy of Stem Cell Physicians.

FREE CONSULTATION

Have a Question About
a Treatment?

Get a quick call-back from Dr. Nina Gupta's team. We'll answer all your questions and help you find the right treatment plan — at no cost.